Cargando…

Injectable long acting antiretroviral for HIV treatment and prevention: perspectives of potential users

BACKGROUND: The use of long acting injectable (LAA) antiretroviral drugs may be an alternative option for HIV treatment and prevention. Our study focused on patient perspectives to understand which individuals, among people with HIV (PWH) and pre-exposure prophylaxis (PrEP) users, would constitute t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Slama, Laurence, Porcher, Raphael, Linard, Françoise, Chakvetadze, Catherine, Cros, Agnès, Carillon, Séverine, Gallardo, Lucille, Viard, Jean-Paul, Molina, Jean-Michel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936705/ https://www.ncbi.nlm.nih.gov/pubmed/36803606 http://dx.doi.org/10.1186/s12879-023-08071-9

Ejemplares similares

Diagnosis, risk factors and management of diabetes mellitus in HIV-infected persons in France: A real-life setting study
por: Kousignian, Isabelle, et al.
Publicado: (2021)

Long-acting injectable antiretrovirals for HIV treatment and prevention
por: Spreen, William R., et al.
Publicado: (2013)

Rates of inappropriate antiretroviral prescription among injection drug users
por: Wood, Evan, et al.
Publicado: (2007)

Long-Acting Injectable Antiretroviral Agents for HIV Treatment and Prevention
por: Kim, Yeon-Sook
Publicado: (2021)

1600. Long-Acting Antiretroviral Injectable: Who Would Benefit?
por: Pogorzelski, Karolina, et al.
Publicado: (2023)

Long-acting injectable antiretroviral therapy: will it change the future of HIV treatment?
por: Brizzi, Marisa, et al.
Publicado: (2023)

Low knowledge of antiretroviral treatments for the prevention of HIV among precarious immigrants from sub-Saharan Africa living in the greater Paris area: Results from the Makasi project
por: Coulibaly, Karna, et al.
Publicado: (2023)

Interest of screening asymptomatic older adults for SARS-CoV-2 in nursing homes
por: Sourdeau, Elise, et al.
Publicado: (2021)

Antiretroviral (ARV) Drug Resistance and HIV-1 Subtypes among Injecting Drug Users in the Coastal Region of Kenya
por: Ng'ong'a, Gabriel O., et al.
Publicado: (2022)

Services integration for injection drug users on antiretroviral therapy for management of HIV epidemic in Estonia
por: Laisaar, Kaja-Triin, et al.
Publicado: (2010)

Poly(ethylene glycol)-b-poly(1,3-trimethylene carbonate) Copolymers for the Formulation of In Situ Forming Depot Long-Acting Injectables
por: Cagnon, Marie-Emérentienne, et al.
Publicado: (2021)

Homelessness and Adherence to Antiretroviral Therapy among a Cohort of HIV-Infected Injection Drug Users
por: Palepu, Anita, et al.
Publicado: (2011)

Factors Associated with Symptoms of Depression among Injection Drug Users Receiving Antiretroviral Treatment in Indonesia
por: Li, Yi, et al.
Publicado: (2014)

Assessing readiness to implement long-acting injectable HIV antiretroviral therapy: provider and staff perspectives
por: Koester, Kimberly A., et al.
Publicado: (2023)

Is Clinical Practice Concordant with the Changes in Guidelines for Antiretroviral Therapy Initiation during Primary and Chronic HIV-1 Infection? The ANRS PRIMO and COPANA Cohorts
por: Krastinova, Evguenia, et al.
Publicado: (2013)

Correction: Is Clinical Practice Concordant with the Changes in Guidelines for Antiretroviral Therapy Initiation during Primary and Chronic HIV-1 Infection? The ANRS PRIMO and COPANA Cohorts
por: Krastinova, Evguenia, et al.
Publicado: (2013)

HIV-1 protease inhibitor drug resistance in Kenyan antiretroviral treatment-naive and -experienced injection drug users and non-drug users
por: Budambula, Valentine, et al.
Publicado: (2015)

The feasibility of an intensive case management program for injection drug users on antiretroviral therapy in St. Petersburg, Russia
por: Shaboltas, Alla V, et al.
Publicado: (2013)

End-user research in support of long-acting systemic antiretroviral delivery systems: insights from qualitative research with providers and target users in South Africa
por: Brown, Morgan S., et al.
Publicado: (2022)

Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy
por: Benning, Lorie, et al.
Publicado: (2020)

2499. Perceptions of and Preferences for Oral or Long-Acting Injectable Antiretroviral Treatment Regimens in the United States and Canada
por: Garris, Cindy, et al.
Publicado: (2019)

Acceptability and feasibility of long-acting injectable antiretroviral therapy for HIV-infected persons who inject drugs in Vietnam: A qualitative study
por: Rutstein, Sarah E., et al.
Publicado: (2022)

Predictors of Weight Change in Male HIV-Positive Injection Drug Users Initiating Antiretroviral Therapy in Hanoi, Vietnam
por: Tang, Alice M., et al.
Publicado: (2011)

Transmitted Drug Resistance Mutations in Antiretroviral-Naïve Injection Drug Users with Chronic HIV-1 Infection in Iran
por: Memarnejadian, Arash, et al.
Publicado: (2015)

Relationship between Regulatory T Cells and Immune Activation in Human Immunodeficiency Virus-Infected Patients Interrupting Antiretroviral Therapy
por: Weiss, Laurence, et al.
Publicado: (2010)

Perceptions of Long-Acting Injectable Antiretroviral Treatment Regimens in a United States Urban Academic Medical Center
por: Koren, David E., et al.
Publicado: (2020)

The vulnerability of men to virologic failure during antiretroviral therapy in a public routine clinic in Burkina Faso
por: Penot, Pauline, et al.
Publicado: (2014)

Detection of Extensive Cross-Neutralization between Pandemic and Seasonal A/H1N1 Influenza Viruses Using a Pseudotype Neutralization Assay
por: Labrosse, Béatrice, et al.
Publicado: (2010)

Acute Hepatitis B Infection After a Switch to Long-Acting Cabotegravir and Rilpivirine
por: Pintado, Claire, et al.
Publicado: (2020)

Injectable Antiretroviral Drugs: Back to the Future
por: Berruti, Marco, et al.
Publicado: (2021)

Treatment Adherence with Early Prescription of Long-Acting Injectable Antipsychotics in Recent-Onset Schizophrenia
por: Viala, Annie, et al.
Publicado: (2012)

Are Patients and Their Providers Talking About Long-Acting Injectable Antiretroviral Therapy? Penetration into Clinical Encounters at Three U.S. Care Sites
por: Christopoulos, Katerina A, et al.
Publicado: (2022)

Factors Associated with Preferences for Long-Acting Injectable Antiretroviral Therapy Among Adolescents and Young People Living with HIV in South Africa
por: Toska, Elona, et al.
Publicado: (2023)

Acceptability, Feasibility, and Appropriateness of Implementation of Long-acting Injectable Antiretrovirals: A National Survey of Ryan White Clinics in the United States
por: Tarfa, Adati, et al.
Publicado: (2023)

Ubiquitin-specific protease USP2-45 acts as a molecular switch to promote α(2)δ-1-induced downregulation of Ca(v)1.2 channels
por: Rougier, Jean-Sebastien, et al.
Publicado: (2014)

Benefits and limitations of different study designs for long‐acting antiretroviral therapy among people living with HIV with viremia
por: Gandhi, Monica, et al.
Publicado: (2023)

Incidence and risk factors for liver enzymes elevations in highly treatment-experienced patients switching from enfuvirtide to raltegravir: a sub-study of the ANRS-138 EASIER trial
por: de Castro, Nathalie, et al.
Publicado: (2016)

Immigrants facing Covid 19 containment in France : An ordinary hardship of disaffiliation
por: Carillon, Séverine, et al.
Publicado: (2020)

Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals
por: Martinez, Valrie, et al.
Publicado: (2012)

Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals
por: Martinez, Valérie, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_k9icfed1o06ta5469qfr0vgiql